Form 8-K - Current report:
SEC Accession No. 0001104659-25-004711
Filing Date
2025-01-21
Accepted
2025-01-21 07:01:34
Documents
13
Period of Report
2025-01-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm253756d1_8k.htm   iXBRL 8-K 23805
  Complete submission text file 0001104659-25-004711.txt   196155

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ogn-20250115.xsd EX-101.SCH 3009
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogn-20250115_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogn-20250115_pre.xml EX-101.PRE 22356
15 EXTRACTED XBRL INSTANCE DOCUMENT tm253756d1_8k_htm.xml XML 3684
Mailing Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302
Business Address 30 HUDSON STREET FL 33 JERSEY CITY NJ 07302 551-430-6000
Organon & Co. (Filer) CIK: 0001821825 (see all company filings)

EIN.: 464838035 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40235 | Film No.: 25540406
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)